The apparently very short time interval between NOX reporting the preliminary results for treatment of pancreatic cancer and FDA Orphan drug status is remarkable. Looks like the FDA sees this treatment as a potential significant breakthrough and have wasted no time in granting the Orphan Status
- Forums
- ASX - By Stock
- NOX
- Ann: US FDA grants Orphan Drug Designation for CRO-67
Ann: US FDA grants Orphan Drug Designation for CRO-67, page-2
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
|
|||||
Last
10.5¢ |
Change
0.009(9.38%) |
Mkt cap ! $30.68M |
Open | High | Low | Value | Volume |
9.6¢ | 10.5¢ | 9.6¢ | $3.808K | 37.69K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 10937 | 9.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 36068 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 10937 | 0.096 |
3 | 110989 | 0.091 |
1 | 99321 | 0.090 |
1 | 100000 | 0.086 |
1 | 100000 | 0.081 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 36068 | 2 |
0.110 | 24430 | 3 |
0.115 | 90513 | 2 |
0.120 | 96624 | 2 |
0.125 | 343081 | 7 |
Last trade - 15.59pm 02/09/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |